The World Health Organization reports more than 90% of children breathe air so polluted that it puts their health at risk.

It's important to note that clinical trials for children are different than trials for adults. Here is what you should know.

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Conventional treatments for allergic rhinitis may also improve asthma outcomes in patients with both conditions. Read now!

As long as the parents are informed, that is 90 percent of the battle, just making them aware of what’s going on,” said ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®? (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a ...

The 5th edition of Manipal Hospital Old Airport Road's flagship workshop series, Handling Unexpected Emergencies (HUE), ...

HOPKINS, Minn. — A father pleaded guilty to second-degree manslaughter on Monday after prosecutors said he failed to seek ...